APO Research
Talk to an analyst

APO RESEARCH · REPORT

Estrogen and Progesterone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Estrogen and Progesterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchEstrogen and Progesterone Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Estrogen and Progesterone Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Estrogen and Progesterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estrogen and Progesterone Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Estrogen and Progesterone Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Estrogen and Progesterone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Estrogen and Progesterone include Aspen Pharmacare, Besins Healthcare, Dr.Kade Pharmazeutische Fabrik, F.I.S.-FABBRICA, Gedeon Richter, Jenapharm, MERCK SERONO, N.V.Organon and Novartis Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Estrogen and Progesterone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Estrogen and Progesterone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Estrogen and Progesterone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Estrogen and Progesterone market size, projected growth trends, production technologies, key applications, and end-use industries.

Estrogen and Progesterone Segment by Company

Aspen Pharmacare

Besins Healthcare

Dr.Kade Pharmazeutische Fabrik

F.I.S.-FABBRICA

Gedeon Richter

Jenapharm

MERCK SERONO

N.V.Organon

Novartis Pharma

Orion

Pfizer Healthcare

Teva Pharma

AstraZeneca

Bayer

Eli Lilly

Novo Nordisk

Abbott

Estrogen and Progesterone Segment by Type

Estrogen

Progesterone

Estrogen and Progesterone Segment by Application

Hospital

Pharmacy

Department of Endocrinology

Estrogen and Progesterone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estrogen and Progesterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estrogen and Progesterone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estrogen and Progesterone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Estrogen and Progesterone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Estrogen and Progesterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Estrogen and Progesterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Estrogen and Progesterone Industry Trends Table 2. Estrogen and Progesterone Industry Drivers Table 3. Estrogen and Progesterone Industry Opportunities and Challenges Table 4. Estrogen and Progesterone Industry Restraints Table 5. Global Estrogen and Progesterone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Estrogen and Progesterone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Estrogen and Progesterone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Estrogen and Progesterone Sales Market Share by Manufacturers Table 9. Global Estrogen and Progesterone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Estrogen and Progesterone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Estrogen and Progesterone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Estrogen and Progesterone Manufacturers, Product Type & Application Table 13. Global Estrogen and Progesterone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Estrogen and Progesterone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Estrogen Table 17. Major Manufacturers of Progesterone Table 18. Global Estrogen and Progesterone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 20. Global Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 21. Global Estrogen and Progesterone Sales Market Share by Type (2021-2026) Table 22. Global Estrogen and Progesterone Sales Market Share by Type (2027-2032) Table 23. Global Estrogen and Progesterone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Estrogen and Progesterone Revenue by Type (2021-2026) & (K Units) Table 25. Global Estrogen and Progesterone Revenue by Type (2027-2032) & (K Units) Table 26. Global Estrogen and Progesterone Revenue Market Share by Type (2021-2026) Table 27. Global Estrogen and Progesterone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Department of Endocrinology Table 31. Global Estrogen and Progesterone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 33. Global Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 34. Global Estrogen and Progesterone Sales Market Share by Application (2021-2026) Table 35. Global Estrogen and Progesterone Sales Market Share by Application (2027-2032) Table 36. Global Estrogen and Progesterone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Estrogen and Progesterone Revenue by Application (2021-2026) & (K Units) Table 38. Global Estrogen and Progesterone Revenue by Application (2027-2032) & (K Units) Table 39. Global Estrogen and Progesterone Revenue Market Share by Application (2021-2026) Table 40. Global Estrogen and Progesterone Revenue Market Share by Application (2027-2032) Table 41. Global Estrogen and Progesterone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Estrogen and Progesterone Sales by Region (2021-2026) & (K Units) Table 43. Global Estrogen and Progesterone Sales Market Share by Region (2021-2026) Table 44. Global Estrogen and Progesterone Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Estrogen and Progesterone Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 48. North America Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 49. Europe Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 51. Europe Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 58. Global Estrogen and Progesterone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Estrogen and Progesterone Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Estrogen and Progesterone Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Estrogen and Progesterone Revenue Market Share by Region (2021-2026) Table 62. Global Estrogen and Progesterone Revenue Market Share by Region (2027-2032) Table 63. Aspen Pharmacare Company Information Table 64. Aspen Pharmacare Business Overview Table 65. Aspen Pharmacare Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aspen Pharmacare Estrogen and Progesterone Product Portfolio Table 67. Aspen Pharmacare Recent Development Table 68. Besins Healthcare Company Information Table 69. Besins Healthcare Business Overview Table 70. Besins Healthcare Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Besins Healthcare Estrogen and Progesterone Product Portfolio Table 72. Besins Healthcare Recent Development Table 73. Dr.Kade Pharmazeutische Fabrik Company Information Table 74. Dr.Kade Pharmazeutische Fabrik Business Overview Table 75. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio Table 77. Dr.Kade Pharmazeutische Fabrik Recent Development Table 78. F.I.S.-FABBRICA Company Information Table 79. F.I.S.-FABBRICA Business Overview Table 80. F.I.S.-FABBRICA Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio Table 82. F.I.S.-FABBRICA Recent Development Table 83. Gedeon Richter Company Information Table 84. Gedeon Richter Business Overview Table 85. Gedeon Richter Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Gedeon Richter Estrogen and Progesterone Product Portfolio Table 87. Gedeon Richter Recent Development Table 88. Jenapharm Company Information Table 89. Jenapharm Business Overview Table 90. Jenapharm Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jenapharm Estrogen and Progesterone Product Portfolio Table 92. Jenapharm Recent Development Table 93. MERCK SERONO Company Information Table 94. MERCK SERONO Business Overview Table 95. MERCK SERONO Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. MERCK SERONO Estrogen and Progesterone Product Portfolio Table 97. MERCK SERONO Recent Development Table 98. N.V.Organon Company Information Table 99. N.V.Organon Business Overview Table 100. N.V.Organon Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. N.V.Organon Estrogen and Progesterone Product Portfolio Table 102. N.V.Organon Recent Development Table 103. Novartis Pharma Company Information Table 104. Novartis Pharma Business Overview Table 105. Novartis Pharma Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Novartis Pharma Estrogen and Progesterone Product Portfolio Table 107. Novartis Pharma Recent Development Table 108. Orion Company Information Table 109. Orion Business Overview Table 110. Orion Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Orion Estrogen and Progesterone Product Portfolio Table 112. Orion Recent Development Table 113. Pfizer Healthcare Company Information Table 114. Pfizer Healthcare Business Overview Table 115. Pfizer Healthcare Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Pfizer Healthcare Estrogen and Progesterone Product Portfolio Table 117. Pfizer Healthcare Recent Development Table 118. Teva Pharma Company Information Table 119. Teva Pharma Business Overview Table 120. Teva Pharma Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Teva Pharma Estrogen and Progesterone Product Portfolio Table 122. Teva Pharma Recent Development Table 123. AstraZeneca Company Information Table 124. AstraZeneca Business Overview Table 125. AstraZeneca Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. AstraZeneca Estrogen and Progesterone Product Portfolio Table 127. AstraZeneca Recent Development Table 128. Bayer Company Information Table 129. Bayer Business Overview Table 130. Bayer Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bayer Estrogen and Progesterone Product Portfolio Table 132. Bayer Recent Development Table 133. Eli Lilly Company Information Table 134. Eli Lilly Business Overview Table 135. Eli Lilly Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Eli Lilly Estrogen and Progesterone Product Portfolio Table 137. Eli Lilly Recent Development Table 138. Novo Nordisk Company Information Table 139. Novo Nordisk Business Overview Table 140. Novo Nordisk Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Novo Nordisk Estrogen and Progesterone Product Portfolio Table 142. Novo Nordisk Recent Development Table 143. Abbott Company Information Table 144. Abbott Business Overview Table 145. Abbott Estrogen and Progesterone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Abbott Estrogen and Progesterone Product Portfolio Table 147. Abbott Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Estrogen and Progesterone Distributors List Table 151. Estrogen and Progesterone Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Estrogen and Progesterone Product Image Figure 2. Global Estrogen and Progesterone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estrogen and Progesterone Market Size (2021-2032) & (US$ Million) Figure 4. Global Estrogen and Progesterone Sales (2021-2032) & (K Units) Figure 5. Global Estrogen and Progesterone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Estrogen and Progesterone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Estrogen Image Figure 9. Progesterone Image Figure 10. Global Estrogen and Progesterone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Estrogen and Progesterone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Estrogen and Progesterone Sales Market Share by Type (2021-2032) Figure 13. Global Estrogen and Progesterone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Estrogen and Progesterone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Estrogen and Progesterone Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Pharmacy Image Figure 18. Department of Endocrinology Image Figure 19. Global Estrogen and Progesterone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Estrogen and Progesterone Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Estrogen and Progesterone Sales Market Share by Application (2021-2032) Figure 22. Global Estrogen and Progesterone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Estrogen and Progesterone Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Estrogen and Progesterone Revenue Market Share by Application (2021-2032) Figure 25. North America Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 27. U.S. Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 32. Germany Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 39. China Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 47. Brazil Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Estrogen and Progesterone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Estrogen and Progesterone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Estrogen and Progesterone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Figure 58. North America Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Figure 60. Europe Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Estrogen and Progesterone Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Estrogen and Progesterone Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Estrogen and Progesterone Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Estrogen
  • Progesterone
Applications
  • Hospital
  • Pharmacy
  • Department of Endocrinology
Companies covered
  • Aspen Pharmacare
  • Besins Healthcare
  • Dr.Kade Pharmazeutische Fabrik
  • F.I.S.-FABBRICA
  • Gedeon Richter
  • Jenapharm
  • MERCK SERONO
  • N.V.Organon
  • Novartis Pharma
  • Orion
  • Pfizer Healthcare
  • Teva Pharma
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • Novo Nordisk
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Estrogen and Progesterone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Estrogen and Progesterone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Estrogen and Progesterone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Estrogen and Progesterone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Estrogen and Progesterone Market Dynamics
  1. 2.1 Estrogen and Progesterone Industry Trends
  2. 2.2 Estrogen and Progesterone Industry Drivers
  3. 2.3 Estrogen and Progesterone Industry Opportunities and Challenges
  4. 2.4 Estrogen and Progesterone Industry Restraints
3 Estrogen and Progesterone Market by Manufacturers
  1. 3.1 Global Estrogen and Progesterone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Estrogen and Progesterone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Estrogen and Progesterone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Estrogen and Progesterone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Estrogen and Progesterone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Estrogen and Progesterone Manufacturers, Product Type & Application
  7. 3.7 Global Estrogen and Progesterone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Estrogen and Progesterone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Estrogen and Progesterone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Estrogen and Progesterone Tier 1, Tier 2, and Tier 3
4 Estrogen and Progesterone Market by Type
  1. 4.1 Estrogen and Progesterone Type Introduction
  2. 4.1.1 Estrogen
  3. 4.1.2 Progesterone
  4. 4.2 Global Estrogen and Progesterone Sales by Type
  5. 4.2.1 Global Estrogen and Progesterone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Estrogen and Progesterone Sales by Type (2021-2032)
  7. 4.2.3 Global Estrogen and Progesterone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Estrogen and Progesterone Revenue by Type
  9. 4.3.1 Global Estrogen and Progesterone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Estrogen and Progesterone Revenue by Type (2021-2032)
  11. 4.3.3 Global Estrogen and Progesterone Revenue Market Share by Type (2021-2032)
5 Estrogen and Progesterone Market by Application
  1. 5.1 Estrogen and Progesterone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Department of Endocrinology
  5. 5.2 Global Estrogen and Progesterone Sales by Application
  6. 5.2.1 Global Estrogen and Progesterone Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Estrogen and Progesterone Sales by Application (2021-2032)
  8. 5.2.3 Global Estrogen and Progesterone Sales Market Share by Application (2021-2032)
  9. 5.3 Global Estrogen and Progesterone Revenue by Application
  10. 5.3.1 Global Estrogen and Progesterone Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Estrogen and Progesterone Revenue by Application (2021-2032)
  12. 5.3.3 Global Estrogen and Progesterone Revenue Market Share by Application (2021-2032)
6 Global Estrogen and Progesterone Sales by Region
  1. 6.1 Global Estrogen and Progesterone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Estrogen and Progesterone Sales by Region (2021-2032)
  3. 6.2.1 Global Estrogen and Progesterone Sales by Region (2021-2026)
  4. 6.2.2 Global Estrogen and Progesterone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Estrogen and Progesterone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Estrogen and Progesterone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Estrogen and Progesterone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Estrogen and Progesterone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Estrogen and Progesterone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Estrogen and Progesterone Revenue by Region
  1. 7.1 Global Estrogen and Progesterone Revenue by Region
  2. 7.1.1 Global Estrogen and Progesterone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Estrogen and Progesterone Revenue by Region (2021-2026)
  4. 7.1.3 Global Estrogen and Progesterone Revenue by Region (2027-2032)
  5. 7.1.4 Global Estrogen and Progesterone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Estrogen and Progesterone Revenue (2021-2032)
  8. 7.2.2 North America Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Estrogen and Progesterone Revenue (2021-2032)
  11. 7.3.2 Europe Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Estrogen and Progesterone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Estrogen and Progesterone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Estrogen and Progesterone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Pharmacare
  2. 8.1.1 Aspen Pharmacare Company Information
  3. 8.1.2 Aspen Pharmacare Business Overview
  4. 8.1.3 Aspen Pharmacare Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Pharmacare Estrogen and Progesterone Product Portfolio
  6. 8.1.5 Aspen Pharmacare Recent Developments
  7. 8.2 Besins Healthcare
  8. 8.2.1 Besins Healthcare Company Information
  9. 8.2.2 Besins Healthcare Business Overview
  10. 8.2.3 Besins Healthcare Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Besins Healthcare Estrogen and Progesterone Product Portfolio
  12. 8.2.5 Besins Healthcare Recent Developments
  13. 8.3 Dr.Kade Pharmazeutische Fabrik
  14. 8.3.1 Dr.Kade Pharmazeutische Fabrik Company Information
  15. 8.3.2 Dr.Kade Pharmazeutische Fabrik Business Overview
  16. 8.3.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio
  18. 8.3.5 Dr.Kade Pharmazeutische Fabrik Recent Developments
  19. 8.4 F.I.S.-FABBRICA
  20. 8.4.1 F.I.S.-FABBRICA Company Information
  21. 8.4.2 F.I.S.-FABBRICA Business Overview
  22. 8.4.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio
  24. 8.4.5 F.I.S.-FABBRICA Recent Developments
  25. 8.5 Gedeon Richter
  26. 8.5.1 Gedeon Richter Company Information
  27. 8.5.2 Gedeon Richter Business Overview
  28. 8.5.3 Gedeon Richter Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gedeon Richter Estrogen and Progesterone Product Portfolio
  30. 8.5.5 Gedeon Richter Recent Developments
  31. 8.6 Jenapharm
  32. 8.6.1 Jenapharm Company Information
  33. 8.6.2 Jenapharm Business Overview
  34. 8.6.3 Jenapharm Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jenapharm Estrogen and Progesterone Product Portfolio
  36. 8.6.5 Jenapharm Recent Developments
  37. 8.7 MERCK SERONO
  38. 8.7.1 MERCK SERONO Company Information
  39. 8.7.2 MERCK SERONO Business Overview
  40. 8.7.3 MERCK SERONO Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MERCK SERONO Estrogen and Progesterone Product Portfolio
  42. 8.7.5 MERCK SERONO Recent Developments
  43. 8.8 N.V.Organon
  44. 8.8.1 N.V.Organon Company Information
  45. 8.8.2 N.V.Organon Business Overview
  46. 8.8.3 N.V.Organon Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 N.V.Organon Estrogen and Progesterone Product Portfolio
  48. 8.8.5 N.V.Organon Recent Developments
  49. 8.9 Novartis Pharma
  50. 8.9.1 Novartis Pharma Company Information
  51. 8.9.2 Novartis Pharma Business Overview
  52. 8.9.3 Novartis Pharma Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Pharma Estrogen and Progesterone Product Portfolio
  54. 8.9.5 Novartis Pharma Recent Developments
  55. 8.10 Orion
  56. 8.10.1 Orion Company Information
  57. 8.10.2 Orion Business Overview
  58. 8.10.3 Orion Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Orion Estrogen and Progesterone Product Portfolio
  60. 8.10.5 Orion Recent Developments
  61. 8.11 Pfizer Healthcare
  62. 8.11.1 Pfizer Healthcare Company Information
  63. 8.11.2 Pfizer Healthcare Business Overview
  64. 8.11.3 Pfizer Healthcare Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Healthcare Estrogen and Progesterone Product Portfolio
  66. 8.11.5 Pfizer Healthcare Recent Developments
  67. 8.12 Teva Pharma
  68. 8.12.1 Teva Pharma Company Information
  69. 8.12.2 Teva Pharma Business Overview
  70. 8.12.3 Teva Pharma Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharma Estrogen and Progesterone Product Portfolio
  72. 8.12.5 Teva Pharma Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca Estrogen and Progesterone Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Bayer
  80. 8.14.1 Bayer Company Information
  81. 8.14.2 Bayer Business Overview
  82. 8.14.3 Bayer Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bayer Estrogen and Progesterone Product Portfolio
  84. 8.14.5 Bayer Recent Developments
  85. 8.15 Eli Lilly
  86. 8.15.1 Eli Lilly Company Information
  87. 8.15.2 Eli Lilly Business Overview
  88. 8.15.3 Eli Lilly Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eli Lilly Estrogen and Progesterone Product Portfolio
  90. 8.15.5 Eli Lilly Recent Developments
  91. 8.16 Novo Nordisk
  92. 8.16.1 Novo Nordisk Company Information
  93. 8.16.2 Novo Nordisk Business Overview
  94. 8.16.3 Novo Nordisk Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Novo Nordisk Estrogen and Progesterone Product Portfolio
  96. 8.16.5 Novo Nordisk Recent Developments
  97. 8.17 Abbott
  98. 8.17.1 Abbott Company Information
  99. 8.17.2 Abbott Business Overview
  100. 8.17.3 Abbott Estrogen and Progesterone Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Estrogen and Progesterone Product Portfolio
  102. 8.17.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Estrogen and Progesterone Value Chain Analysis
  2. 9.1.1 Estrogen and Progesterone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Estrogen and Progesterone Production Mode & Process
  6. 9.2 Estrogen and Progesterone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Estrogen and Progesterone Distributors
  9. 9.2.3 Estrogen and Progesterone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst